Tenaya Therapeutics (TNYA) EBIT (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly EBIT of -$20.1 million for Q1 2026, up 27.14% year-over-year from -$15.8 million in Q1 2025, and up 3.42% quarter-over-quarter from -$20.8 million in Q4 2025.
Tenaya Therapeutics (TNYA) EBIT (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' EBIT history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.
- In Q1 2026, EBIT rose 27.14% year-over-year to -$20.1 million; the TTM figure through Mar 2026 stood at -$85.9 million (up 21.75% YoY), while the FY2025 annual figure was -$93.3 million, up 19.51% from the prior year.
- EBIT for Q1 2026 stood at -$20.1 million, up from -$20.8 million in the prior quarter.
- The five-year high for EBIT was -$20.1 million in Q1 2026, with the low at -$35.1 million in Q2 2023.
- The 5-year median for EBIT is -$30.8 million (2024), against an average of -$28.6 million.
- The sharpest annual moves came in 2022 and 2026: EBIT sank 137.73% in 2022, then increased 27.14% in 2026.
- Tenaya Therapeutics' EBIT stood at -$34.6 million in 2022, then climbed by 8.98% to -$31.4 million in 2023, then climbed by 21.61% to -$24.7 million in 2024, then increased by 15.73% to -$20.8 million in 2025, then advanced by 3.42% to -$20.1 million in 2026.
- Business Quant data shows TNYA's EBIT at -$20.1 million in Q1 2026, -$20.8 million in Q4 2025, and -$20.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Tenaya Therapeutics | 150.58 Mn | 150.58 Mn | - | -44.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -44.09 Mn |
| Mar 31, 2026 | -20.07 Mn |
| Dec 31, 2025 | -20.78 Mn |
| Sep 30, 2025 | -20.94 Mn |
| Jun 30, 2025 | -24.08 Mn |
| Mar 31, 2025 | -27.54 Mn |
| Dec 31, 2024 | -24.65 Mn |
| Sep 30, 2024 | -26.71 Mn |
| Jun 30, 2024 | -30.82 Mn |
| Mar 31, 2024 | -33.76 Mn |
| Dec 31, 2023 | -31.45 Mn |
| Sep 30, 2023 | -30.92 Mn |
| Jun 30, 2023 | -35.10 Mn |
| Mar 31, 2023 | -33.72 Mn |
| Dec 31, 2022 | -34.55 Mn |
| Sep 30, 2022 | -31.30 Mn |
| Jun 30, 2022 | -28.62 Mn |
| Mar 31, 2022 | -31.15 Mn |
| Dec 31, 2021 | -26.16 Mn |
| Sep 30, 2021 | -18.30 Mn |